Saponiqx announces breakthrough in scaling up of stimulon™ cultured plant cell adjuvant

Lexington, mass.--(business wire)--saponiqx, the adjuvant subsidiary of agenus inc. (nasdaq: agen), specializing in saponin-based adjuvant discovery and manufacturing, has achieved a milestone in scaling the production of its stimulon cultured plant cell (cpc) qs-21 adjuvant, designed to amplify the efficiency and endurance of vaccines. this cultured plant cell adjuvant is building upon saponiqx's expertise with its proprietary adjuvant stimulon qs-21, a critical component of effective vaccines.
AGEN Ratings Summary
AGEN Quant Ranking